BARD1 and breast carcinoma: These inconsistent findings regarding the association of the BARD1 Cys557Ser variant to familial breast cancer susceptibility suggest that this mutation might be confined to the specific geographical substructure of the European population (due to regional migration) rather than de novo variant [55].